Cutaneous metastasis of SMARCA4‐deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications
- 29 January 2020
- journal article
- case report
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 47 (6) , 561-565
Abstract
SMARCA4‐deficient thoracic sarcoma (SMARCA4‐DTS) is a recently recognized entity with undifferentiated rhabdoid morphology and mutations in the switch/sucrose nonfermenting BRG1‐associated factors complex. Patients are typically males in their fifth decade with a history of smoking who present with rapidly progressive intrathoracic disease and follow an aggressive clinical course. Metastatic disease is reported in up to 77% of cases; however, to our knowledge, cutaneous metastasis has not been reported nor has it been reported as the initial manifestation of the disease. Recognizing SMARCA4‐DTS from other types of epithelioid tumors that involve the skin is clinically relevant, as targeted therapies for SMARC‐deficient tumors are currently being investigated and early clinical trial data show therapeutic benefit.Keywords
This publication has 9 references indexed in Scilit:
- SMARCA4-deficient Thoracic SarcomasAmerican Journal of Surgical Pathology, 2019
- Cutaneous metastasesDiagnostic Histopathology, 2019
- Skin Adnexal Tumors in Plain Language: A Practical Approach for the General Surgical PathologistArchives of Pathology & Laboratory Medicine, 2019
- Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 studyThe Lancet Oncology, 2018
- A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic PotentialAmerican Journal of Surgical Pathology, 2018
- PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumorsProceedings of the National Academy of Sciences, 2017
- SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behaviorLaboratory Investigation, 2017
- Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entitiesLaboratory Investigation, 2017
- SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomasNature Genetics, 2015